Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: reduced gastric irritation NSAIDs - Oxford Pharmascience

Next Previous
Drug Profile

Research programme: reduced gastric irritation NSAIDs - Oxford Pharmascience

Alternative Names: OXP 006; OXP 007; OXPzero™ Aspirin

Latest Information Update: 06 Oct 2017

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Oxford Pharmascience
  • Class Nonsteroidal anti-inflammatories; Phenylacetates; Salicylic acids; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors; Nitric oxide stimulants; Platelet aggregation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Suspended Musculoskeletal pain
  • Discontinued Cardiovascular disorders

Most Recent Events

  • 27 Sep 2017 Suspended for Musculoskeletal pain in United Kingdom, pending conclusion of a strategic review (PO)
  • 09 Nov 2016 Discontinued for OXPzero™ aspirin programme for Cardiovascular disorders in United Kingdom (PO)
  • 02 Jul 2015 Early research in Cardiovascular disorders in United Kingdom (PO) prior to July 2015
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top